117 related articles for article (PubMed ID: 3653210)
1. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.
Lissoni P; Barni S; Cazzaniga M; Ardizzoia A; Rovelli F; Tancini G; Brivio F; Frigerio F
Oncology; 1995; 52(6):439-42. PubMed ID: 7478427
[TBL] [Abstract][Full Text] [Related]
3. Correlation between changes in prolactin and melatonin serum levels after radical mastectomy.
Lissoni P; Paolorossi F; Barni S; Tancini G; Crispino S; Rovelli F; Ferri L; Esposti G; Esposti D; Fraschini F
Tumori; 1987 Jun; 73(3):263-7. PubMed ID: 3603722
[TBL] [Abstract][Full Text] [Related]
4. Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patients.
Mandalà M; Lissoni P; Ferretti G; Rocca A; Torri V; Moro C; Curigliano G; Barni S
Oncology; 2002; 63(4):370-7. PubMed ID: 12417792
[TBL] [Abstract][Full Text] [Related]
5. HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.
Lissoni P; Messina G; Rovelli F; Brivio F; Fumagalli L; Villa S; Bartolacelli E
In Vivo; 2009; 23(6):987-9. PubMed ID: 20023245
[TBL] [Abstract][Full Text] [Related]
6. Effect of mastectomy versus mastectomy plus adjuvant ovariectomy on prolactin response to TRH in breast cancer.
Ayala D; Lissoni P; Archili C; Barni S; Roveda G; Giacomelli M; Bissi A
J Biol Regul Homeost Agents; 1990; 4(4):150-2. PubMed ID: 2128988
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin.
Barni S; Lissoni P; Brivio F; Fumagalli L; Merlini D; Cataldo M; Rovelli F; Tancini G
Tumori; 1994 Jun; 80(3):212-5. PubMed ID: 8053079
[TBL] [Abstract][Full Text] [Related]
8. Prolactin serum level in patients with breast cancer.
Cohen AD; Cohen Y; Maislos M; Buskila D
Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
[TBL] [Abstract][Full Text] [Related]
9. Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancer.
Barni S; Lissoni P; Mandelli D; Archili C; Real G; Sormani AL; Caprotti R; Tancini G
Int J Biol Markers; 1991; 6(2):103-6. PubMed ID: 1890313
[TBL] [Abstract][Full Text] [Related]
10. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
[TBL] [Abstract][Full Text] [Related]
11. A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour.
Messina G; Lissoni P; Brivio F; Rovelli F; Fumagalli L; Bartolacelli E; Mazza U; Colombo E; Bertoglio A
In Vivo; 2008; 22(6):845-8. PubMed ID: 19181018
[TBL] [Abstract][Full Text] [Related]
12. The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results.
Bignami A; Lissoni P; Brivio F; Galbiati F; Pescia S; Messina G; Frontini L; Meregalli S; Gardani GS
Int J Biol Markers; 2005; 20(1):60-4. PubMed ID: 15832774
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer.
Lissoni P; Vaghi M; Ardizzoia A; Fumagalli E; Tancini G; Gardani G; Conti A; Maestroni GJ
Neuro Endocrinol Lett; 2001; 22(1):27-9. PubMed ID: 11335876
[TBL] [Abstract][Full Text] [Related]
14. Postoperative hyperprolactinaemia and early recurrence rate in breast cancer.
Lissoni P; Sormani AL; Tancini G; Cattaneo G; Archili C; Mandelli D; Crispino S; Paolorossi F; Barni S
Eur J Cancer; 1990; 26(9):953-6. PubMed ID: 2149021
[TBL] [Abstract][Full Text] [Related]
15. Serum prolactin after chest wall surgery: elevated levels after mastectomy.
Herman V; Kalk WJ; de Moor NG; Levin J
J Clin Endocrinol Metab; 1981 Jan; 52(1):148-51. PubMed ID: 7451641
[TBL] [Abstract][Full Text] [Related]
16. Endocrinological study of the dopaminergic regulation of prolactin release in metastatic breast cancer.
Mandalà M; Lissoni P; Ardizzoia A; Barni S; Rovelli F; Confalonieri G; Malugani F; Moro C; Fumagalli G; Giani L; Tancini G
Tumori; 1999; 85(6):494-7. PubMed ID: 10774572
[TBL] [Abstract][Full Text] [Related]
17. Control of prolactin secretion.
Benker G; Jaspers C; Häusler G; Reinwein D
Klin Wochenschr; 1990 Dec; 68(23):1157-67. PubMed ID: 2126309
[TBL] [Abstract][Full Text] [Related]
18. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
19. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
20. A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.
Lissoni P; Bucovec R; Malugani F; Ardizzoia A; Villa S; Gardani GS; Vaghi M; Tancini G
Anticancer Res; 2002; 22(2B):1131-4. PubMed ID: 12168912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
